slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
150,841-150,900 of 319,975
16
The slide uses a process flow diagram to illustrate the clinical trial structure (Screening, Part A, Part B).Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
17
The slide outlines clinical trial parameters for a drug candidate (Nefecon) targeting IgA Nephropathy.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
18
The slide uses a bulleted list to detail operational resilience in a clinical trial setting.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
19
The slide uses a combination of a horizontal timeline and callout boxes to detail specific clinical trial milestones.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
20
Focuses on clinical trial progression timelines and methodology.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
21
The slide uses a matrix-like layout to categorize strategic pillars.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
22
The slide uses a two-column layout to contrast market opportunity with the societal cost of the disease.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
23
The slide presents findings from both qualitative interviews and a quantitative survey to validate market demand.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Beat · Market SizeLoop · Cost Of Inaction1 hit
24
The slide outlines specific payor requirements (prior auth, nephrologist prescription, etc.) and strategic opportunities to improve the value proposition.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
25
The network diagram illustrates the connectivity between KOLs (orange) and the broader nephrologist community (blue).Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
26
The slide uses a structured table format to align market opportunity with strategic execution.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
27
The slide uses a bulleted list to explain the pathophysiology of PBC and AIH.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
28
The slide highlights the lack of targeted anti-inflammatory therapies for PBC.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
29
Includes prevalence map and clinical statistics on treatment side effects and relapse rates.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
30
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
31
Includes checkmarks for completed items; 2020 is marked with an asterisk regarding COVID-19 uncertainty.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Loop · Why Now1 hit
32
The slide uses a numbered list format to present key value drivers including clinical status, regulatory pathway, and market opportunity.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank Loop · Why Now1 hit
33
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
34
The chart demonstrates a strong correlation (R^2=0.90) between proteinuria reduction and ESRD risk reduction, supporting the use of proteinuria as a surrogate endpoint.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
35
The table shows percentage changes or values for various renal markers. The 16mg dose consistently shows stronger efficacy (higher percentage reductions in protein/albumin) compared to 8mg.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
36
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
37
Calliditas Therapeutics | IPO Presentation Deck | 38 slidesCalliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
38
The slide uses a 'hub-spoke' visual arrangement for the board members, though they are presented as a list of cards.Calliditas Therapeutics | IPO Presentation Deck | 38 slides · Calliditas Therapeutics
Pitch deck Investment bank 1 hit
01
Features Glenn Youngkin as Co-CEO.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Setup1 hit
02
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Setup1 hit
03
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · SetupLoop · Golden Circle1 hit
04
The slide uses a process-style layout to categorize strategic priorities.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · SetupLoop · Golden Circle1 hit
05
The slide uses a chevron-based list structure to map strategic focus areas to specific quantitative metrics.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
06
The chart uses a dual-axis approach to show both absolute dollar amounts and margin percentages.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
07
Includes logos of portfolio companies: DEPT, Sequent, MAK-SYSTEM, Adams Outdoor Advertising.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
08
The slide uses a donut chart for portfolio breakdown and a table for historical MOIC performance.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
09
Includes a disclaimer regarding non-recurring insurance recoveries in 2017 and 2018.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
10
The slide uses a split layout: left side provides company context and strategic rationale, right side details the income generation model.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
11
The chart illustrates a significant gap in passive ownership between CG (0%) and its peers (11-14%), suggesting a catalyst for future share demand.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
12
Uses a 'plus' sign diagram to represent the additive nature of the three pillars of the investment thesis.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
13
Slide 13 of the presentation.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
14
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
15
Data as of March 31, 2020.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
16
Includes data for 2016-2020. Financial metrics are in $mm, AUM in $bn.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
17
Includes data for Total AUM, Fee-Earning AUM, and financial performance metrics (FRE, Net Realized Performance Revenues, Distributable Earnings).Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
18
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
19
Carlyle | Investor Conference Presentation Deck | 26 slidesCarlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
20
Includes footnotes regarding dividend policy and share eligibility.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
21
Includes footnotes regarding specific adjustments and accounting periods.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
22
Contains footnotes (1-4) explaining adjustments and references to other pages.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
23
The table is split into two main sections: Revenue Reconciling Items and Expense Reconciling Items.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
24
Contains detailed footnotes explaining adjustments for NGP Management, Fortitude Re, and CLO loans.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
25
Includes a detailed footnote regarding the conversion from a partnership to a corporation on January 1, 2020.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
26
Includes eliminations column to reconcile consolidated figures.Carlyle | Investor Conference Presentation Deck | 26 slides · The Carlyle Group
Conference presentation Investor relations Beat · Evidence1 hit
01
Clever Leaves | SPAC Presentation Deck | 16 slidesClever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
02
The slide uses a grid layout to contrast the leadership teams of the two merging entities.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
03
Clever Leaves | SPAC Presentation Deck | 16 slidesClever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
04
Uses a value-chain style matrix to show geographic footprint vs operational capabilities.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank Beat · SolutionLoop · Mece Breakdown1 hit
05
Includes a legend for operational types and employee count tiers.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
06
Clever Leaves | SPAC Presentation Deck | 16 slidesClever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
07
Uses external media quotes and geographic data to validate the market thesis.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank Beat · ProblemLoop · Why Now1 hit
08
Uses a 'VS' comparison structure to establish a cost advantage multiplier for the target geography.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
09
The slide uses a pyramid structure to illustrate market segmentation based on regulatory certification status.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank Beat · Competition1 hit
10
The slide uses an aerial photograph with annotations to delineate different phases of facility construction.Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit
11
Includes a bar chart embedded within the table for the final row (Average Price per Gram).Clever Leaves | SPAC Presentation Deck | 16 slides · Clever Leaves
Pitch deck Investment bank 1 hit